Oslo, 17 December 2024
Reference is made to the announcement by Observe Medical ASA (the “Company” or “Observe Medical”, OSE ticker “OBSVR”) on 5 December 2024 regarding the final results of the subsequent offering in the Company and the waiver of the condition for completion of the share capital increase of NOK 10,630,629.88, through the issuance of 40,887,038 new shares to Navamedic ASA, at a subscription price of 0.40 per share, in connection with the conversion by Navamedic ASA of a loan amount of NOK 16,354,815.20 under a loan from Navamedic ASA to the Company (the “Loan Conversion”).
The Loan Conversion has today been completed through the registration of the share capital increase pertaining to the Loan Conversion with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). The Company’s registered share capital is NOK 75,107,805.50 divided into 288,876,175 shares, each with a nominal value of NOK 0.26.
The new shares will be issued in the Norwegian Central Securities Depository (ES-OSL) on the listed ISIN NO 0010865009 and are expected to be delivered to Navamedic ASA’s ES-OSL account later today on 17 December 2024.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical:
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialisation of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.
About The Author
